Stock Events

Eastwood Bio-Medical Canada 

$0.69
0
-$0.51-42.19% Tuesday 17:56

Statistics

Day High
0.69
Day Low
0.58
52W High
1.2
52W Low
0.58
Volume
31,000
Avg. Volume
0
Mkt Cap
47.79M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

29JunConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q2 2021
Q1 2022
Q1 2022
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0003

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EWOOF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap236.8B
Novartis is a global healthcare company that manufactures drugs similar to those produced by Eastwood Bio-Medical, targeting similar diseases and conditions.
Pfizer
PFE
Mkt Cap158.95B
Pfizer is a large pharmaceutical company that develops and markets medications and supplements that compete directly in the healthcare market with Eastwood Bio-Medical.
GSK
GSK
Mkt Cap80.5B
GlaxoSmithKline focuses on a broad range of pharmaceutical products, including those in the same therapeutic areas as Eastwood Bio-Medical.
Merck &
MRK
Mkt Cap320.27B
Merck is known for its extensive range of health products that could directly compete with Eastwood Bio-Medical's offerings in various medical conditions.
Johnson & Johnson
JNJ
Mkt Cap352.53B
Johnson & Johnson offers a wide array of medical devices, pharmaceuticals, and health-related products, overlapping with Eastwood Bio-Medical's market.
Abbvie
ABBV
Mkt Cap295.34B
AbbVie operates in similar therapeutic areas, potentially competing with Eastwood Bio-Medical in the field of biopharmaceuticals.
AMGEN
AMGN
Mkt Cap166.77B
Amgen, a biotech firm, develops treatments that could compete with Eastwood Bio-Medical's products, particularly in the specialized biomedicine sector.
Bristol-Myers Squibb
BMY
Mkt Cap80.39B
Bristol-Myers Squibb, with its diverse range of pharmaceutical products, competes in the same healthcare space as Eastwood Bio-Medical.
Lilly(Eli) &
LLY
Mkt Cap869.21B
Eli Lilly and Company produces pharmaceutical products that target similar conditions and diseases as those treated by Eastwood Bio-Medical.
Sanofi
SNY
Mkt Cap125.78B
Sanofi operates globally in the pharmaceutical sector, offering products that could directly compete with those of Eastwood Bio-Medical in various health categories.

About

Pharmaceuticals: Other
Health Technology
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
Show more...
CEO
Country
CA
ISIN
CA27783W1059

Listings